MUMBAI (Reuters) - Lupin Ltd, India's third-largest drugmaker, reported a 12 percent fall in third-quarter profit that was in line with analysts' expectations.
Net profit for the quarter ended Dec. 31 was 5.30 billion rupees ($78.3 million), down from 6.01 billion rupees a year earlier.
($1 = 67.6900 Indian rupees)
(Reporting by Zeba Siddiqui in Mumbai; Editing by Gopakumar Warrier)